"Diabetic Retinopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Descriptor ID |
D003930
|
| MeSH Number(s) |
C11.768.257 C14.907.320.382 C19.246.099.500.382
|
| Concept/Terms |
Diabetic Retinopathy- Diabetic Retinopathy
- Diabetic Retinopathies
- Retinopathies, Diabetic
- Retinopathy, Diabetic
|
Below are MeSH descriptors whose meaning is more general than "Diabetic Retinopathy".
Below are MeSH descriptors whose meaning is more specific than "Diabetic Retinopathy".
This graph shows the total number of publications written about "Diabetic Retinopathy" by people in this website by year, and whether "Diabetic Retinopathy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 2 | 1 | 3 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 2 | 3 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 1 | 2 |
| 2008 | 3 | 0 | 3 |
| 2009 | 6 | 0 | 6 |
| 2011 | 4 | 1 | 5 |
| 2012 | 6 | 1 | 7 |
| 2013 | 2 | 1 | 3 |
| 2014 | 4 | 0 | 4 |
| 2015 | 2 | 0 | 2 |
| 2016 | 4 | 1 | 5 |
| 2017 | 3 | 0 | 3 |
| 2018 | 0 | 1 | 1 |
| 2019 | 3 | 0 | 3 |
| 2020 | 3 | 0 | 3 |
| 2021 | 4 | 0 | 4 |
| 2022 | 8 | 0 | 8 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetic Retinopathy" by people in Profiles.
-
Geographic variation in diabetic retinopathy screening within the Veterans Health Administration. Prim Care Diabetes. 2023 10; 17(5):429-435.
-
Optimal Frequency of Retinopathy Screening in Adolescents With Type 1 Diabetes: Markov Modeling Approach Based on 30 Years of Data. Diabetes Care. 2022 10 01; 45(10):2383-2390.
-
The Safety and Biological Activity of OTT166, a Novel Topical Selective Integrin Inhibitor for the Treatment of Diabetic Eye Disease: A Phase 1b Study. Ophthalmic Surg Lasers Imaging Retina. 2022 10; 53(10):553-560.
-
Loss of TRPV2-mediated blood flow autoregulation recapitulates diabetic retinopathy in rats. JCI Insight. 2022 09 22; 7(18).
-
Multifocal pupillographic objective perimetry for assessment of early diabetic retinopathy and generalised diabetes-related tissue injury in persons with type 1 diabetes. BMC Ophthalmol. 2022 Apr 13; 22(1):166.
-
Fenofibrate, which reduces risk of sight-threatening diabetic retinopathy in type 2 diabetes, is associated with early narrowing of retinal venules: a FIELD trial substudy. Intern Med J. 2022 04; 52(4):676-679.
-
Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudy. Diabetes Res Clin Pract. 2022 Apr; 186:109835.
-
Comparison of Visual Acuity Results Between ATS-HOTV and E-ETDRS Testing Methods in Children With Optic Pathway Gliomas. Transl Vis Sci Technol. 2022 03 02; 11(3):10.
-
Safety and Outcomes of Intravitreal Aflibercept in Diabetic Macular Edema - A Systematic Review. Curr Pharm Des. 2022; 28(21):1758-1768.
-
Tofacitinib Ameliorates Retinal Vascular Leakage in a Murine Model of Diabetic Retinopathy with Type 2 Diabetes. Int J Mol Sci. 2021 Nov 02; 22(21).